KemPharm's opioid painkiller gets FDA approval, shares soar

(Reuters) - KemPharm Inc said on Friday the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain, sending the shares of the drugmaker up as much as 36 percent in late afternoon trading.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news